Ranibizumab 2.3mg Inj (approved By Cdsco For All Six Indications As 1)wet
amd, 2)diabetic Macular Edema, 3)retinal Vein Occlusion, 4)myopic Cnvm,
5)proliferative Diabetic Retinopathy, 6)retinopathy Of Prematurity) .#* Ranibizumab 2.3mg Inj (approved By Cd
TK ID 528290223
Document Type
Tender Notice
Tender Summary
Ranibizumab 2.3mg Inj (approved By Cdsco For All Six Indications As 1)wet
amd, 2)diabetic Macular Edema, 3)retinal Vein Occlusion, 4)myopic Cnvm,
5)proliferative Diabetic Retinopathy, 6)retinopathy Of Prematurity) .#* Ranibizumab 2.3mg Inj (approved By Cd